We recently published a list of 10 Worst ARK Stocks To Buy According to Short Sellers. In this article, we are going to take ...
Barclays analyst Peter Lawson assigned a Buy rating to Nurix Therapeutics (NRIX – Research Report) today and set a price target of $31.00. The ...
During the last three months, 9 analysts shared their evaluations of Nurix Therapeutics NRIX, revealing diverse outlooks from ...
In this article, we are going to take a look at where Nurix Therapeutics, Inc. (NASDAQ:NRIX) stands against the other small-cap biotech stocks. The biotechnology sector is expanding quickly due to ...
SAN FRANCISCO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat ...
Fintel reports that on December 6, 2024, BMO Capital initiated coverage of Nurix Therapeutics (NasdaqGM:NRIX) with a Outperform recommendation. As of December 3, 2024, the average one-year price ...
Massachusetts Financial Services Co. MA lowered its stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) by 29.3% ...